VitaDAO Review 2026: Crypto-Funded Longevity Research

VitaDAO is a community-owned collective that funds early-stage longevity science. Its stated mission is to extend human healthspan and lifespan through accelerated research, open collaboration and funding structures that align incentives across the field.

The homepage reports 31 projects funded, about $4.7M in funding deployed and about $60.0M in project fully diluted value. It also lists 8 IP-NFTs generated and 3 companies founded. Example deals include a $350,000 equity investment in a prodrug discovery platform and IP-NFT funding for autophagy and codon suppression research.

The project has also added the Vita App, a private health record that combines labs and wearable data with an AI assistant. This moves VitaDAO from a pure research funder toward a consumer health product. The homepage also talks about using purpose-built AI to speed up how research ideas are generated and validated.

The project does not publish audits, team details or treasury figures on its homepage.

VitaDAO pools community capital and directs it to early-stage longevity research. Projects are listed with a funding type, such as equity or IP-NFT, and an amount. IP-NFTs are tokens that represent rights to a research project's intellectual property, so the community can fund a lab and hold a stake in what it produces.

VITA holders take part in governance decisions about research funding and the direction of the community. The homepage reports projects at stages from target discovery and drug discovery to preclinical and clinical development, which shows how funding is spread across the research pipeline.

Alongside the DAO, the Vita App lets users bring lab results and wearable data into one encrypted record. Vita AI gives research-informed context on that data. The homepage says users hold the key to their record, but it does not explain the encryption or storage design in detail.

VitaDAO does not publish a fee schedule on its homepage. There is no stated charge for the research-funding mechanism itself, and the project does not describe any DAO or token fees.

The Vita App is described as having a free plan with no card required. Pricing for any paid tiers is not published on the homepage, so check the app and the store page. Buying VITA on a market means paying that venue's trading fees plus Ethereum network gas.

The homepage does not publish smart-contract audits, a legal structure description, or treasury custody details. Anyone interacting with VITA or related contracts should look for audit reports and governance documentation before committing funds. VITA is described as an Ethereum token.

Investment risk is high. Early-stage drug and target discovery projects often fail, and token markets for DAO governance tokens can be thin. One listing shows very low daily trading volume, and snippets disagree on the price, so check current data yourself.

The Vita App handles sensitive health information. The homepage says the record is encrypted by default and that the user holds the key, but it does not describe the technical design. Read the privacy policy and terms of use before connecting labs or wearables. The app gives research-informed context, not medical advice.

VitaDAO is for people interested in longevity research who are comfortable with DAO governance and the high risk of early-stage science funding. The Vita App also suits users who want labs and wearable data in one record. It is not a fit for anyone seeking predictable returns.